KalVista Pharmaceuticals (KALV) Return on Assets (2015 - 2025)
KalVista Pharmaceuticals recorded quarterly Return on Assets of 0.0% in Q3 2025, down 67.67% quarter-over-quarter from 0.0% in Q2 2025, and little changed year-over-year from 0.0% in Q3 2024.
KalVista Pharmaceuticals' Return on Assets history runs 11 years deep, the most recent figure standing at 0.0% for Q3 2025.
- In Q3 2025, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM figure through Jul 2025 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Assets came in at 0.0% for Q3 2025 at KalVista Pharmaceuticals, down from 0.0% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q2 2025 to a low of 0.01% in Q1 2024.
- A 5-year average of 0.0% and a median of 0.0% in 2022 frame the typical range for Return on Assets.
- On a YoY basis, Return on Assets climbed as much as 0 bps in 2021 and fell as far as 0 bps in 2021.
- KalVista Pharmaceuticals' Return on Assets stood at 0.0% in 2021, then plunged by 109 bps to 0.01% in 2022, then fell by 26 bps to 0.01% in 2023, then surged by 68 bps to 0.0% in 2024, then retreated by 15 bps to 0.0% in 2025.
- According to Business Quant data, Return on Assets over the past three periods registered 0.0%, 0.0%, and 0.0% for Q3 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -0.01% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -0.01% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.00% |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 0.00% |
| Apr 30, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Oct 31, 2024 | 0.00% |
| Jul 31, 2024 | 0.00% |
| Apr 30, 2024 | 0.00% |
| Jan 31, 2024 | -0.01% |
| Oct 31, 2023 | -0.01% |
| Jul 31, 2023 | -0.01% |
| Apr 30, 2023 | -0.01% |
| Jan 31, 2023 | -0.01% |
| Oct 31, 2022 | -0.01% |
| Jul 31, 2022 | -0.01% |
| Apr 30, 2022 | 0.00% |
| Jan 31, 2022 | 0.00% |
| Oct 31, 2021 | 0.00% |
| Jul 31, 2021 | 0.00% |
| Apr 30, 2021 | 0.00% |
| Jan 31, 2021 | -0.01% |
| Oct 31, 2020 | -0.01% |
| Jul 31, 2020 | 0.00% |
| Apr 30, 2020 | 0.00% |
| Jan 31, 2020 | 0.00% |
| Oct 31, 2019 | 0.00% |
| Jul 31, 2019 | 0.00% |
| Apr 30, 2019 | 0.00% |
| Jan 31, 2019 | 0.00% |
| Oct 31, 2018 | 0.00% |
| Jul 31, 2018 | 0.00% |
| Apr 30, 2018 | 0.00% |
| Jan 31, 2018 | 0.00% |
| Oct 31, 2017 | -0.01% |
| Jul 31, 2017 | -0.01% |
| Apr 30, 2017 | -0.01% |
| Mar 31, 2016 | 0.00% |
| Dec 31, 2015 | 0.00% |
| Sep 30, 2015 | 0.00% |
| Jun 30, 2015 | 0.00% |
| Mar 31, 2015 | -0.02% |